The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods Of Using Pyruvate Kinase Activators - EP3307271

The patent EP3307271 was granted to Agios Pharmaceuticals on Sep 13, 2023. The application was originally filed on Jun 10, 2016 under application number EP16808374A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3307271

AGIOS PHARMACEUTICALS
Application Number
EP16808374A
Filing Date
Jun 10, 2016
Status
Granted And Under Opposition
Aug 11, 2023
Publication Date
Sep 13, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZJun 13, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
BOTTI & FERRARIJun 11, 2024BOTTI & FERRARIADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS8785450
DESCRIPTIONWO2012151451
INTERNATIONAL-SEARCH-REPORTUS2014155408
INTERNATIONAL-SEARCH-REPORTUS2014323467
OPPOSITIONWO2012151451
SEARCHWO2012151451

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents